Key result
Ranolazine successfully treated atrial fibrillation in two highly symptomatic patients who were refractory to amiodarone.
Why the study?
Does ranolazine improve symptoms in amiodarone-refractory highly symptomatic patients with atrial fibrillation?
Does ranolazine improve symptoms in amiodarone-refractory highly symptomatic patients with atrial fibrillation?
Ranolazine may serve as an effective alternative therapy for patients with highly symptomatic atrial fibrillation that is refractory to amiodarone.
Answers are grounded in this paper and cite their sources.
May support ranolazine in select refractory AF cases; leaves open need for randomized confirmation.
Atrial fibrillation is the most common sustained cardiac arrhythmia which is often troublesome to manage. Currently, rhythm and rate control medications are the mainstays of therapy. In 2 amiodarone-refractory highly symptomatic patients, an innovative approach using ranolazine, which selectively acts on Na+ channels and delays atrial depolarization, was tried successfully.
No takes yet. Share an insight, caveat, or question.
Vaishnav et al. (2014) studied this question. Ranolazine successfully treated atrial fibrillation in two highly symptomatic patients who were refractory to amiodarone.
Synapse has enriched 10 related papers. Consider them for comparative context: